您现在位置： -医药产业>>研究报告>>English reports>>English reports>> 浏览医药行业研究报告

Rifampicin Bulk Drug Report

讯：

Market Research Report on Chinese Bulk Rifampicin Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd Published: July 2006 Format: Hardcopy and Adobe PDF Price: US$1,500 Contact: Mr. Bian chenghua Ms. Wu huifang Tel.: 86-10-68012929-2116/2101 Fax: 86-10-68012929-2008 E-mail: bianch@healthoo.com wuhf@healthoo.com //m.limatoxi.com Directory 1. Overview 1.1 Definition of Erythromycin Thiocyanate 1.2 Antimicrobic mechanism 1.3 Backgroud of Research & Development 1.4 Mainly uses 2. Domestic production status 2.1 Overview of production 2.2 Output,export volume,enterprise share 2.3 production status of Rifamycin-S sodium 3. Key enterprises 3.1 Tonglian Group Shenyang Antibiotic Factory 3.2 Hubei XinGang Biochemical Company 3.3 Luohe Nanjiecun Pharmaceutical Group 3.4 Zhengzhou Minzhong Pharmaceutical Co., Ltd 3.5 Others 4. Proposed projects and projects under construction 5. Price trend 6. Export analysis 6.1 General status of export 6.2 Export Destination (Countries or Regions) and market feature 6.3 Export volume and value structure of main enterprises 7. Brief remark